Numbers of subjects remaining at each censoring time point are indicated<p><b>Copyright information:</b></p><p>Taken from "Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study"</p><p></p><p>International Journal of Clinical Practice 2008;62(5):679-687.</p><p>Published online 01 May 2008</p><p>PMCID:PMC2324208.</p><p>© 2008 The Authors Journal compilation © 2008 Blackwell Publishing Ltd</p
Context—The duration of treatment after achieving a satisfactory response is an unanswered question ...
International audienceOBJECTIVE: To compare the rate of relapse as a function of antipsychotic treat...
This is the author accepted manuscript. The final version is available from the American Medical Ass...
Aripiprazole, a second-generation antipsychotic medication, has been increas...
Background: Aripiprazole, a second-generation antipsychotic medication, has been increasingly used i...
<p>HP: erradication therapy; F: Fludarabine; Chemo: Chemotherapy.</p>*<p>Time to relapse in months.<...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
© 2018 Torres-Llenza et al. The lack of long-term medication adherence is a challenge in the treatme...
Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia Pigott ...
Background: Aripiprazole, a second-generation antipsychotic medication, has been increasingly used i...
Objective: The integration of new treatments into the market and routine clinical practice should be...
David J MuzinaCenter for Mood Disorders Treatment and Research, Cleveland Clinic Neurological Instit...
Several observational studies have found a higher risk of recurrence/relapse of depression for patie...
BACKGROUND: Aripiprazole, a second-generation antipsychotic medication, has been increasingly us...
Background: Antidepressants are effective in the prevention of relapse after remission from an acute...
Context—The duration of treatment after achieving a satisfactory response is an unanswered question ...
International audienceOBJECTIVE: To compare the rate of relapse as a function of antipsychotic treat...
This is the author accepted manuscript. The final version is available from the American Medical Ass...
Aripiprazole, a second-generation antipsychotic medication, has been increas...
Background: Aripiprazole, a second-generation antipsychotic medication, has been increasingly used i...
<p>HP: erradication therapy; F: Fludarabine; Chemo: Chemotherapy.</p>*<p>Time to relapse in months.<...
<p>Odds ratios higher than 1 reflect a higher discontinuation rate due to adverse events in the subs...
© 2018 Torres-Llenza et al. The lack of long-term medication adherence is a challenge in the treatme...
Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia Pigott ...
Background: Aripiprazole, a second-generation antipsychotic medication, has been increasingly used i...
Objective: The integration of new treatments into the market and routine clinical practice should be...
David J MuzinaCenter for Mood Disorders Treatment and Research, Cleveland Clinic Neurological Instit...
Several observational studies have found a higher risk of recurrence/relapse of depression for patie...
BACKGROUND: Aripiprazole, a second-generation antipsychotic medication, has been increasingly us...
Background: Antidepressants are effective in the prevention of relapse after remission from an acute...
Context—The duration of treatment after achieving a satisfactory response is an unanswered question ...
International audienceOBJECTIVE: To compare the rate of relapse as a function of antipsychotic treat...
This is the author accepted manuscript. The final version is available from the American Medical Ass...